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The recombinant expression of soluble proteins in Escherichia coli continues
to be a major bottleneck in structural genomics. The establishment of reliable
protocols for the performance of small-scale expression and solubility testing is
an essential component of structural genomic pipelines. The SSGCID Protein
Production Group at the University of Washington (UW-PPG) has developed a
high-throughput screening (HTS) protocol for the measurement of protein
recovery from immobilized metal-afﬁnity chromatography (IMAC) which
predicts successful puriﬁcation of hexahistidine-tagged proteins. The protocol
is based on manual transfer of samples using multichannel pipettors and 96-well
plates and does not depend on the use of robotic platforms. This protocol
has been applied to evaluate the expression and solubility of more than 4000
proteins expressed in E. coli. The UW-PPG also screens large-scale preparations
for recovery from IMAC prior to puriﬁcation. Analysis of these results show
that our low-cost non-automated approach is a reliable method for the HTS
demands typical of large structural genomic projects. This paper provides a
detailed description of these protocols and statistical analysis of the SSGCID
screening results. The results demonstrate that screening for proteins that yield
high recovery after IMAC, both after small-scale and large-scale expression,
improves the selection of proteins that can be successfully puriﬁed and will yield
a crystal structure.
1. Introduction
The greatest challenge, and indeed the most vital requisite, for any
laboratory or group involved in structural genomics is the ability to
produce hundreds of proteins in parallel (high throughput) and test
them using a method that is both cost-effective and reliable in
predicting those proteins that can be puriﬁed and will yield protein
structures (Benita et al., 2006). Because every protein is structurally
unique and characteristically distinct, it is often very difﬁcult to
achieve desirable success rates in standardized high-throughput
protein-production pipelines, and this is a major contributor to the
ﬁscal and technical burdens faced by many structural genomic
projects. Thus, there is a growing demand for the establishment of
conditions and methods for expression and screening that (i) are
concordant with and can be applied to a great range of proteins and
species, (ii) reduce the overall effort and cost of expression trials
(Folkers et al., 2004; Alzari et al., 2006) and (iii) are a reliable
predictor of protein puriﬁcations that provide the adequate amounts
and quality of protein needed for subsequent successful structural
studies (Berrow et al., 2006).
In an attempt to address these demands, the University of
Washington Protein Production Group (UW-PPG), as part of the
NIAID-funded Seattle Structural Genomics Center for Infectious
Diseases (SSGCID), has designed a non-automated approach to
high-throughput screening (HTS) that employs auto-induction
methods for the controlled expression of recombinant proteins in
Escherichia coli (Studier, 2005), immobilized metal-afﬁnity chroma-
tography (IMAC) for the puriﬁcation of hexahistidine-taggedproteins and SDS–PAGE analyses for the visual evaluation of
expression and recovery levels after IMAC, all of which are
performed in a 96-well format (for a complete workﬂow, see Fig. 1).
This approach proves to be low-cost and accessible because it does
not require the use of expensive robotic platforms. It also allows the
entire HTS process, from the transformation of recombinants into
host expression strains to the visualization of expression results on
protein gels, to be completed in a week, providing reliable predictions
of protein-expression and IMAC-recoverability levels for large-scale
applications within a reasonable timeframe.
2. Materials and methods
2.1. High-throughput cloning
2.1.1. Overview of AVA0421 vector features. Derived from the
pET14b vector, the leader sequence of AVA0421 contains a T7
promoter followed by an N-terminal hexahistidine (6 His) nickel-
afﬁnity tag and a modiﬁed human rhinovirus 3C (HRV-3C) protease
recognition site, as well as two restriction sites used for ligation-
independent cloning (LIC; Aslanidis & de Jong, 1990; Alexandrov et
al., 2004; Mehlin et al., 2006; Quartley et al., 2009; Fig. 2). Placement
of the 3C cleavage site between the 6 His tag and the open reading
frame (ORF) allows the use of subtractive IMAC methods during
protein puriﬁcation to further purify the recombinant protein and
remove the cleaved tag (Bryan et al., 2011). The AVA0421 vector
contains the ampR gene (also known as blaTEM1), which confers
resistance to ampicillin and carbenicillin for the selection of recom-
binant constructs during the cloning and expression stages (Fig. 2a).
2.1.2. Preparation of LIC-ready vector. AVA0421 plasmid DNA
was puriﬁed from large E. coli cultures using a Maxi-Prep kit
(Qiagen, Valencia, California, USA). The puriﬁed DNAwas digested
with PmeI enzyme (NEB, Ipswich, Massachusetts, USA) and run on
a 1% TAE agarose gel (40 mM Tris base, 2 mM EDTA, 5.7% acetic
acid, 1% agarose pH 7) containing ethidium bromide (EtBr;
40 mgl
 1) for 1.25 h at 150 V. The band of linearized plasmid was
excised and gel-puriﬁed using a gel-extraction kit (Qiagen, Valencia,
California, USA). The puriﬁed linear DNA was then digested with
NruI enzyme (NEB, Ipswich, Massachusetts) and further puriﬁed
by ethanol precipitation. Following ethanol precipitation, the DNA
concentration was checked using a Nanodrop ND-1000 spectro-
photometer (Thermo Scientiﬁc, Waltham, Massachusetts, USA) and
the DNA was diluted in 1  TE buffer (10 mM Tris–HCl, 0.1 mM
EDTA pH 8) to a concentration of approximately 100 ng ml
 1.T h e
T4 DNA polymerase-treatment step that followed made use of the
exonuclease function of the enzyme to create overhangs on the 50
vector ends (Fig.2b). The reaction was carried out at 295 K for 30 min
in the presence of only dATP so that the reaction stopped when the
enzymeencounteredan adenine nucleotide. The T4DNApolymerase
was heat-inactivated at 348 K for 25 min and 100 ml aliquots of the
LIC-ready vector were frozen and stored at 193 K. The LIC-ready
AVA0421 remained stable for many months at this temperature and
the small size of the aliquots ensured that the LIC-ready vector was
generally only thawed once prior to use.
2.1.3. High-throughput cloning procedure. Genes encoding the
selected protein targets were PCR-ampliﬁed in a 96-well format using
either genomic DNA or cDNA as a template, depending on whether
introns were predicted to be present. Cycling conditions were chosen
laboratory communications
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Figure 1
Standard workﬂow based on UW-PPG’s current cloning, HTS and LSE protocols. Cloning and HTS procedures are carried out manually in 96-well plates and can be
completed in two weeks. LSE and screens are performed in sets of 24 using the LEX bioreactor and can be carried out in one week, with the induction step proceeding over
the weekend. See Bryan et al. (2011) for a detailed protein-puriﬁcation workﬂow.based on the GC content of the template(s) being used and an effort
was made to group targets with the same template DNA or similar
GC content together so that the PCR reactions could be carried out
as efﬁciently as possible (Supplementary Table 1
1). For targets with a
high GC content (>60% of the coding DNA) Phusion polymerase
(Finnzymes, Woburn, Massachusetts, USA) and 4% dimethyl sulf-
oxide (DMSO) was used. Otherwise, Hi-Fidelity polymerase (Roche,
Basel, Switzerland) was used without DMSO. The primers used to
amplify the insert genes had an LIC sequence appended to their 50
ends that was complementary to the restriction sites/LIC sequences
in the vector. After PCR ampliﬁcation, the entire 50 ml PCR reaction
was run for 1.25 h at 150 Von a 1% TAE agarose gel with EtBr. The
PCR products were excised from the gel (after imaging and size
veriﬁcation) and puriﬁed using a 96-well gel-extraction kit (Qiagen,
Valencia, California, USA). Following this, the products were treated
with T4 DNA polymerase (NEB, Ipswich, Massachusetts, USA) in
the presence of 2.5 mM dTTP to create unique single-stranded
overhangs on the 50 ends of the insert that can pair with the corre-
sponding LIC sites on the digested and T4-treated vector as shown in
laboratory communications
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Figure 2
(a) AVA0421 vector map. (b) Ligation-independent cloning (LIC) site of AVA0421 and LIC-ready reaction of inserts.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: EN5455).Fig. 2. At this point, 2 ml of the T4-treated insert and 1 ml of treated
vector were incubated together at ambient temperature, generally
293–295 K, for 5–30 min. The annealing reaction was stopped by the
addition of 1 ml2 5m M EDTA followed by a heat-shock transfor-
mation (10 min on ice, followed by 45 s at 315 K and then ice for
30 min) into NovaBlue E. coli ampliﬁcation strain (EMD Biosciences,
Gibbstown, New Jersey, USA). The LIC plasmid constructs were
puriﬁed from the ampliﬁcation host using a 96-well Turbo Miniprep
kit (Qiagen, Valencia, California, USA). The puriﬁed plasmids were
then transformed into the expression host strain for expression
screening.
2.2. High-throughput screening (HTS)
2.2.1. Transformation into expression host strain. The expression
of SSGCID proteins requires transformation of clone plasmid DNA
into an E. coli host that carries the DE3 gene encoding T7 RNA
polymerase. SSGCID targets that passed the cloning stage were
transformed into BL21(DE3)R3 Rosetta Oxford chemically compe-
tent E. coli expression strain, which carries the CAT gene that allows
chloramphenicol resistance. The cells were prepared in-laboratory,
arranged in 96-well plates and stored at 193 K. The transformations
were performed by manually transferring 3 ml recombinant plasmid
into 120 ml thawed competent cells using an LTS multichannel
pipettor (Rainin, Oakland, California) followed by incubation on ice
for 20 min and a heat shock at 315 K for 45 s. The cells were left to
incubate on ice for a further 20 min. The transformed cells were
rescued by pipetting 100 ml into a 96-well deep well block (Costar,
Lowell, Massachusetts, USA) containing 500 ml pre-warmed LB
medium followed by incubation at 310 K for 1 h on a titer plate
shaker (Lab-Line Instruments, Melrose Park, Illinois, USA) with
vigorous shaking. The rescued cells were centrifuged brieﬂy at
2000 rev min
 1 using a Sorvall RC 5C Plus centrifuge ﬁtted with a
SH-3000 rotor and a PN11770 96-well plate holder and 500 ml of the
supernatant was removed before the cells were resuspended in the
remaining medium and plated onto pre-warmed LB–agar with the
appropriate antibiotic selection (50 mgm l
 1 ampicillin, 50 mgm l
 1
carbenicillin and 34 mgm l
 1 chloramphenicol; GoldBio, St Louis,
Missouri, USA). A positive-control E. coli transformant known to
express soluble recombinant protein was streaked out from a glycerol
stock and screened with the restof theset to ensure consistencyofthe
HTS. The plates were incubated overnight at 310 K to allow colonies
to grow.
2.2.2. Inoculation of non-inducing medium. Using a P20 micro-
pipette tip, single colonies from freshly transformed E. coli cells
were scraped and used to inoculate 820 ml PA-0.5G non-inducing
medium [sterile H2O, 1 mM MgSO4,0 . 1   metals mix (1000  stock:
50 mM FeCl3 6H2O, 20 mM CaCl2,1 0 m M MnCl2 4H2O, 10 mM
ZnSO4 7H2O, 2 mM CoCl2.6H2O, 2 mM CuCl2 2H2O, 2 mM
NiCl2 6H2O, 2 mM Na2MoO4 2H2O, 2 mM Na2SeO3 5H2O, 2 mM
H3BO3 in 50 mM HCl), 0.5% glucose, 1  NPS (100 mM PO4
3 ,
25 mM SO4
2 ,5 0m M NH4
+, 100 mM Na
+,5 0m M K
+), 100 mg ml
 1
l-methionine and 100 mg ml
 1 17 amino-acid mix (1% of each of the
following l-amino acids: Na
+ Glu, Asp, Lys–HCl, Arg–HCl, His–HCl,
Ala, Pro, Gly, Thr, Ser, Gln, Asn, Val, Leu, Ile, Phe and Trp)]
supplemented with appropriate selection in 96-well blocks. The
cultures were grown overnight (about 16 h ) by incubation at ambient
temperature, generally 293–295 K, with vigorous mixing using a plate
shaker. The next day, the PA-0.5G cultures were incubated for an
additional 3 h at 310 K to ensure proper growth of all samples. A
20 ml aliquot of culture was set aside for the inoculation of auto-
inducing medium and 10% glycerol stocks were prepared by pipet-
ting 200 ml 80% glycerol and 600 ml PA-0.5G medium into the
remaining cultures. The glycerol stocks were ﬂash-frozen in liquid
nitrogen and stored at 193 K. DNA-sequence validation of recom-
binants and subsequent larger scale investigations referred to this
glycerol stock for starter cultures.
2.2.3. Inoculation of auto-inducing medium.2 0ml of the PA-0.5G
cultures was manually transferred into a 96-well block containing
600 ml ZYP-5052 auto-induction medium [Sterile ZY Broth (10 g l
 1
tryptone, 5 g l
 1 yeast extract), 1 mM MgSO4,1   metals mix, 1 
5052 (0.5% glycerol, 0.05% glucose, 0.2% -lactose monohydrate)
and 1  NPS] supplemented with the correct antibiotics. The block
was sealed with an Airpore sheet (Qiagen, Valencia, California) and
incubated on a plate shaker inside a refrigerated incubator set at
293 K for roughly 27 h to allow the cultures to reach saturation or
early stationary phase. OD600nm values were measured by aliquoting
a 1/10 dilution of cells into a ﬂat-bottom 96-well assay plate (Costar,
Lowell, Massachusetts, USA) and reading the plates on a Synergy HT
multi-mode microplate reader (BioTek, Winooski, Vermont, USA).
The cultures were not harvested until OD600nm readings of at least 0.6
were obtained. Once the induced cells were at the correct density,
they were centrifuged at 4300 rev min
 1 for 30 min at 277 K. After
centrifugation, the supernatant was discarded and the block with the
semi-dry cell pellets was stored at 193 K.
2.2.4. Protein extraction and purification. The cell pellets stored at
193 K were thawed at ambient temperature for 20 min and 600 ml
lysis buffer [20 mM HEPES pH 7.0, 500 mM NaCl, 5% glycerol, 0.5%
CHAPS (A.G. Scientiﬁc Inc., San Diego, California, USA), 30 mM
imidazole, 10 mM MgCl2, 400 mgm l
 1 lysozyme (Sigma, St Louis,
Missouri, USA) and 3 units ml
 1 Benzonase nuclease (EMD
Chemicals, San Diego, California, USA)] was transferred into each
well. The cell pellets were then resuspended by pipetting. After
resuspension, 600 ml lysis buffer was added to each well and the
sample was mixed a second time. The deep well block was then sealed
and incubated at room temperature for 1 h on a titer shaker set to
moderate. After lysis, a 5 ml sample of the crude lysate was prepared
for SDS–PAGE analyses by mixing it with an equal volume of 5 
pink reducing sample buffer with DTT (Thermo Scientiﬁc, Waltham,
Massachusetts, USA) and heating for 5 min at 268 K to denature. The
remaining sample was clariﬁed by centrifugation at 4300 rev min
 1
for 30 min. 825 ml of the soluble supernatant fraction was transferred
into a 96-well block pre-loaded with 200 ml pre-equilibrated Ni
2+
Sepharose beads (GE Healthcare, Piscataway, New Jersey) for HTS
IMAC. The protein/resin mixture was incubated for 15 min at 277 K
with shaking. The protein/resin mixture was then transferred into a
25 mm 96-well ﬁlter plate (Seahorse Labware, North Millerica,
Massachusetts, USA). Using a vacuum apparatus, the Ni
2+ beads
were washed three times, each with 1 ml wash buffer (20 mM HEPES
pH 7.0, 500 mM NaCl, 5% glycerol, 30 mM imidazole). After
washing, IMAC bound proteins were eluted with 100 ml elution
buffer, which was identical to the wash buffer with the exception that
it contained a higher concentration of imidazole (500 mM). 40 mlo f
the IMAC elution sample was then mixed with 10 ml2 . 5   pink
reducing sample buffer and denatured for SDS–PAGE analyses.
2.2.5. SDS–PAGE analysis. High-throughput screen (HTS) samples
were analyzed by SDS–PAGE using eight Criterion Tris–HCl precast
8–16% gels (pre-run at 100 V for 10 min) with a 26-well comb run on
a Criterion Dodeca Cell gel box (Bio-Rad, Hercules, California,
USA). Each gel holds the total and IMAC elution fractions of 12
protein targets (or one row of a 96-well plate). The ﬁrst lane of each
gel was loaded with 8 ml Bench Mark Pre-stained Protein Ladder
(Invitrogen, Carlsbad, California, USA). Total and IMAC elution
fractions for each target were prepared as follows. For the total
laboratory communications
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sample buffer and was denatured by heating at 368 K for 5 min. 10 ml
1  SDS Tris–glycine running buffer (25 mM Tris base, 192 mM
glycine, 0.1% SDS pH 8.3) was added to dilute the samples and 10 ml
of this mixture was loaded onto the gel. For the IMAC-recoverable
fractions, 40 ml IMAC elution fraction was mixed with 10 ml2 . 5   pink
reducing sample buffer and the sample was denatured by heating to
368 K for 5 min. 13 ml of this IMAC elution sample was loaded onto
the gel. The gels were run at 200 V for 50 min. After the run was
complete, the gels were washed two times for 10 min in H2O followed
by staining with GelCode Blue protein stain (Thermo Scientiﬁc,
Waltham, Massachusetts, USA) for 2 h. The gels were destained with
H2O for 2 h to overnight.
The levels of total and IMAC-recoverable expression detected by
SDS–PAGE for each target were scored visually using a standardized
criterion (none, no visible bands, no expression or insoluble; low,
weak band signifying low expression; medium, adequately sized band,
medium expression; high, very large band, high expression; Fig. 3).
The purpose of this system of scoring is to identify those targets that
have a sufﬁcient level of soluble expression to be useful for scale up.
Generally, target proteins that score low to high for total expression
and medium to high for IMAC recoverability are suitable for scaling
up. High-priority protein targets that are expressed at medium to high
levels but do not appear in IMAC elution fractions and thus are
presumed to be insoluble or aggregated are queued for individual-
ization of lysis buffers for rescue efforts (Leibly et al., manuscript in
preparation).
2.3. Large-scale expression (LSE)
2.3.1. LEX bioreactor. In efforts to achieve efﬁcient, reliable and
reproducible large-scale expression (LSE) of recombinant proteins,
the LEX-48 bench-top bioreactor (Harbinger Biotech, Ontario,
Canada) has been utilized for the growth of high-volume bacterial
cultures (Fig. 4). Originally developed by the Structural Genomics
Consortium to meet their needs in solving large numbers of protein
structures (Vedadi et al., 2007), the LEX bioreactor efﬁciently grows
up to 48 l of high-density bacterial cultures. Typically, we express 2 l
volumes of 24 unique protein targets per LEX run.
2.3.2. Large-scale expression procedure. Starter cultures were
prepared by aliquoting 3 ml LB medium containing the appropriate
antibiotic selection into 14 ml snap-cap round-bottom tubes (BD
Biosciences, San Jose, California, USA) and inoculating from the
frozen 10% glycerol stocks prepared during the HTS. The cultures
are incubated for 16 h at 310 K with vigorous shaking.
All components of ZYP-5052 auto-induction medium were freshly
made every week and prepared for the LEX in the following manner:
1800 ml ZY broth and 200 ml Antifoam 204 (Sigma, St Louis,
Missouri, USA) were aliquoted into clean 2 l Pyrex bottles (Corning,
Corning, New York, USA) and autoclaved for 90 min to ensure that
the medium was fully sterilized; 20  NPS and 50  5052 stocks were
autoclaved for 60 min and all other stocks (1 M MgSO4, 1000 
metals mix and 1000  antibiotics (50 mg ml
 1 ampicillin, 50 mg ml
 1
carbenicillin, 34 mg ml
 1 chloramphenicol) were sterilized through a
laboratory communications
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Figure 3
An example of an SDS–PAGE gel displaying the HTS results for 11 M. smegmatis
target proteins. Reading from left to right, the ﬁrst lane shows the protein ladder (in
kDa). The next two lanes show the total (T) and IMAC elution (P) fractions of a
positive control that is known to have high IMAC recovery. The following lanes
represent a total of 11 target proteins of two lanes each, alternating between their T
and P fractions. IMAC-recovery scores are determined by evaluating the size of
each band (as described in x2.2.5), e.g. target s38 A03’s recovery would be scored as
low, s38 A06’s recovery would be scored as medium and s38 A05’s recovery would
be scored as high. Targets s38 A09 and s38 A10 are insoluble and would not be
queued for scale up in LSE.
Figure 4
The LEX-48 bioreactor growing 24 individual 2 l cultures. Its overall design
features an enclosure with a multi-stage replaceable carbon + HEPA ﬁlter forced-
air hood, two water circulators, customizable controls for aeration, efﬁcient water-
bath regulation of temperature conditions and fully sterilizable components.
Figure 5
An example of an SDS–PAGE gel of LSE screens of eight expressed M. smegmatis
target proteins. The two outermost lanes hold the protein ladders (labeled in kDa).
Each target protein-expression preparation occupies three lanes: total expressed
(T), soluble expressed (S) and IMAC elution pure (P) fractions. The variations in
expression levels as seen in this gel are typical. The solubility-scoring system is
identical to that of the HTS (as described in x2.2.5). Target protein recoverability
after IMAC would be scored as low for 2, 3 and 7, medium for 5 and 6, and high for
4 and 8. Target 1 is primarily insoluble and would not be queued for puriﬁcation.0.22 mm ﬁlter (Millipore, Carrigtwohill, Ireland). On the day of LEX
inoculation, the components were mixed to produce the ﬁnal medium
to be used. The 3 ml starter cultures were added to the bottles, sealed
with sparger caps and placed in the LEX bioreactor. The airﬂow was
adjusted evenly for each bottle and they were left to incubate at
298 K for 24 h followed by drop in temperature to 288 K for 72 h.
To reduce the chance of contamination, the bottles were not opened
until harvest.
OD600nm values were not typically monitored for the assessment of
growth for LSEs. Alternatively, at harvest, the LEX cultures were
transferred to clean 2 l centrifuge buckets, pelleted at 4000g using a
Sorvall RC 12 BP centrifuge ﬁtted with an H-12000 swinging-bucket
rotor and themasses of thecell pastes were measured toverify proper
growth (usually in the range of 20–30 g per 2 l culture). The pelleted
cells were ﬂash-frozen in liquid nitrogen and stored at 193 K until
they were selected for protein puriﬁcation.
2.3.3. LSE screens. All LSEs were screened prior to protein puri-
ﬁcation in order to verify expression and IMAC-recovery levels as
predicted by the HTS. Before harvest, 1 ml aliquots were removed
from the 2 l LEX bottles, pelleted at 4000g for 20 min and stored at
193 K. The pellets were subsequently thawed at ambient temperature
and resuspended and lysed for 1 h in 3 ml lysis buffer. For the
preparation of SDS–PAGE analyses, a 4 ml (‘total’) sample was taken
from the cell lysate; the remaining sample was centrifuged at 4000g
for 30 min and a 4 ml (‘soluble’) sample was taken from the super-
natant fraction; 700 ml of the remaining supernatant was exposed to
100 ml pre-equilibrated Ni
2+ Sepharose beads, washed with 2.1 ml
wash buffer, eluted with 100 ml elution buffer and a 10 mlI M A C
elution (‘pure’) sample was taken. All fractions were mixed with 5 
pink reducing sample buffer, denatured by boiling and analyzed via
SDS–PAGE and scored as described in x2.2.5 (Fig. 5).
3. Results and discussion
During the past three years, the SSGCID protein-production pipeline
has conducted thousands of HTSs and LSEs to test the expression
andIMAC recoverability ofrecombinant proteins expressed in E.coli
in both small-scale and large-scale culture formats. Here, we present
analysis of these results to evaluate the success of SSGCID HTS, to
better understand the correlation between HTS results and LSEs, and
to determine the value of performing screens for IMAC-recoverable
proteins in both small-scale and large-scale expression. The ﬁrst goal
of these analyses was to generate an accurate account of the success
rate of HTS as deﬁned by the total number of SSGCID clones with
associated HTS results. From the commencement of the SSGCID
project in February 2008 to December 2010, the UW-PPG high-
throughput cloning pipeline has been successful in producing 4627
unique clones; of these, 4330 (94%) were effectively transformed into
the BL21(DE3)R3 Rosetta Oxford expression strain and passed on
to the HTS pipeline (these ﬁgures do not include those protein
targets that failed during the initial cloning steps nor any of their
subsequent rescue attempts). The 6% failure rate can be attributed to
several different factors, e.g. poor quality of plasmid DNA, low efﬁ-
ciencies of competent cell stocks, the expression of proteins that are
toxic to E. coli and/or human error. A chronological review of HTS
results suggests that the number of clones that failed at the expression
host transformation step has decreased over time. In fact, analysis of
the last six months reveals the current failure rate to be under 1%.
The improved success rate was likely to be a result of practical
experience gained during the ﬁrst three years of the project and the
careful optimization of standard operating procedures (SOP), which
ultimately led to the SOP described in this paper. Furthermore, the
low failure rate suggests that a manual non-automated approach can
be a reliable method for HTS applications.
Upon visual analyses of SDS–PAGE gels of the 4330 clones that
passed through the HTS pipeline, approximately 56% were observed
to produce protein that could be recovered after elution from IMAC
(IMAC-recoverable protein targets). Of these, 39% were scored as
high-recovery, 30% as moderate-recovery and 31% as low-recovery
protein targets (Fig. 6). An important measure of the strength of a
standardized protocol for high-throughput protein production is its
laboratory communications
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Figure 6
HTS IMAC recovery results (high, medium or low) and LSE screening success rates.
Figure 7
HTS IMAC recovery success rates (y axis) of 25 commonly screened species (x
axis), where HTS success is deﬁned by the number of preparations that had either
low, medium or high IMAC recovery divided by the total screened and multiplied
by 100. 1, Plasmodium falciparum;2 ,Coccidioides immitis;3 ,Mycobacterium bovis;
4, M. leprae;5 ,Toxoplasma gondii;6 ,M. ulcerans;7 ,Borrelia burgdorferi;8 ,
Anaplasma phagocytophilum;9 ,M. tuberculosis; 10, Entamoeba histolytica; 11,
Rickettsia prowazekii; 12, Babesia bovis; 13, Encephalitozoon cuniculi; 14,
M. thermoresistible; 15, M. avium; 16, Cryptosporidium parvum; 17, M. abscessus;
18, Burkholderia pseudomallei; 19, Bartonella henselae; 20, M. marinum; 21,
Ehrlichia chaffeensis; 22, M. paratuberculosis; 23, Giardia lamblia; 24, Brucella
abortus; 25, M. smegmatis.applicability toa variety ofspecies. Our HTS SOP has been successful
in predicting IMAC-recoverable protein levels in over 30 different
species. Of the 25 most commonly screened species, results show that
the HTS IMAC-recoverable protein success rate, where success is
considered as high, medium or low recovery, ranges from 27% for
Plasmodium falciparum to 77% for Mycobacterium smegmatis
(Fig. 7). The purpose of HTS is to identify good candidates for LSE
based on their recovery from small-scale IMAC. However, a
comparison of HTS results with those from LSE revealed that some
protein targets that scored as IMAC-recoverable proteins in HTS
failed to be IMAC recoverable at the LSE step. To date, we have
completed 1771 LSEs for protein targets that have shown IMAC-
recoverable proteins in HTS and 178 of these protein targets failed to
be recoverable at the LSE step, which represents a failure rate of10%
(Fig. 6). Further analysis revealed a strong correlation between HTS
recovery scores and LSE failures. The majority of the protein targets
that failed recovery at the LSE step had low HTS scores (61%),
followed by targets with medium (30%) and high (9%) HTS scores
(Fig. 6). Dividing the results of the LSEs by their HTS IMAC-
recovery scores, those LSEs with low HTS scores had a 26% failure
rate, those LSEs with a medium HTS score had a 9% failure rate and
those with a high HTS score had only a 2% failure rate (Fig. 8a).
Furthermore, a comparative assessment of HTS and LSE IMAC-
recovery scores demonstrates that HTS successfully predicted high
and low recovery levels in LSE in 48% and 59% of the cases,
respectively (Fig. 8b). However, HTS predictions for protein targets
with medium scores were not as consistent with LSE screening
results. While 38% of these HTS medium-scored protein targets gave
comparable medium scores in LSE, 37% were found to have low LSE
scores and 25% were found to have high LSE scores. We would not
want to exclude these high LSE-scoring proteins that would be lost if
we did not upscale medium-scoring HTS proteins, as the high LSE-
scoring proteins are 39% more likely to yield crystal structures than
medium or low recovery scored LSE proteins (Fig. 9; see discussion
in the next paragraph). This discordance between HTS and LSE
screening may be attributed to a number of factors, including
differences in growth, sample preparation and handling methods used
for HTS and LSE, and perhaps inconsistencies arising from the
somewhat subjective nature of the scoring method. Nevertheless,
these results indicate that HTS screening was valuable in predicting
which clones were worthwhile in performing LSEs. The results
suggest that if LSEs are limiting and all other factors are equal, we
should favour medium and high HTS scores for LSEs to avoid high
failure rates and low expression while capturing the maximum
number of high IMAC-recoverable proteins in LSE, as these are the
most likely to yield protein structures.
Comparisons between LSE scores and successful protein puriﬁ-
cations reveal that failure rates for puriﬁcation are higher for targets
with low LSE scores (14%) than protein targets with medium (5%)
and high scores (4%) (Fig. 9). Thus, selecting proteins with medium
and high LSE scores would reduce the failure rate of puriﬁcation by
about two-thirds compared with the failure rate of low expressors.
Analysis of LSEs that led to protein structures demonstrates that
proteins with high scores in LSEs had a 19% probability of producing
a structure, compared with proteins with low and medium LSE scores
which had a 13–14% probability of yielding a structure (Fig. 9). Thus,
a protein with a high soluble LSE score was approximately 39% more
likely to give a structure than a protein with a medium or low soluble
LSE expression score. Since one goal of our structural genomics
group is to produce as many structures as possible, the results suggest
that high IMAC-recoverable proteins in LSE screens should be
prioritized for puriﬁcation and crystal trials if all other priorities are
equal. In conclusion, we feel that the results presented demonstrate
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Figure 9
LSE screening IMAC-recovery results, protein-puriﬁcation and structure-determination success rates.
Figure 8
(a) Relationship between HTS IMAC-recovery scores (x axis) and LSE success (y
axis, left) and failure rates (y axis, right). (b) A comparison of HTS IMAC-recovery
scores (x axis) and LSE IMAC-recovery results (y axis).value for both the HTS and LSE protein-screening assays and we
plan to continue both screens. To achieve maximal success and efﬁ-
ciency, all protein targets that show high or medium recovery scores
in HTS will be prioritized for LSE and high IMAC-recoverable
proteins in the LSE screen will be prioritized for puriﬁcation and
crystallography trials.
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